The effect of zoledronic acid and high-dose vitamin D on function after hip fractures. A prospective cohort study
Ημερομηνία
2022Γλώσσα
en
Λέξη-κλειδί
Επιτομή
Purpose: Hip fractures are associated with functional decline and increased mortality. The aim of this study was to investigate the effect of zoledronic acid and high-dose vitamin D on function and mortality after hip fractures. Patients and methods: Forty-five patients received zoledronic acid and high dose of vitamin D during hospitalization after fracture management. These patients were compared with a control group of 46 patients. Pre- and postoperative prospectively collected data including ASA score, Charlson comorbidity score, presence of dementia, Vitamin D, and the Barthel index were available. Final follow-up was performed after one year. Primary outcome was patients’ function at final follow-up as measured with Barthel index score. Secondary outcomes included mortality, assessment of pain, and complications. Results: Barthel index score at final follow-up was decreased in both groups. There was no significant difference in Barthel index between the two groups (15.5 ± 5.0 vs 15.8 ± 5.8, p = 0.850). However, the Barthel index in the control group decreased beyond the smallest detectable change (3 points). Mortality was statistically different between groups (8.8% vs 28.2%, p = 0.047). Complications and pain at final follow-up were not different between groups. Multivariate analysis revealed that preoperative Barthel index and Charlson comorbidity score independently affected function at final follow-up. Logistic regression analysis disclosed that not receiving active treatment and complications were associated with increased mortality. Conclusions: Medical treatment after surgical management of hip fractures results in reduced mortality and lessens the functional decline associated with these fractures. © 2021, The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.
Collections
Related items
Showing items related by title, author, creator and subject.
-
Failure in diagnosis and under-treatment of osteoporosis in elderly patients with fragility fractures
Bougioukli S., Κollia P., Koromila T., Varitimidis S., Hantes M., Karachalios T., Malizos Κ.Ν., Dailiana Z.H. (2019)We evaluated whether osteoporosis is adequately managed and treated in patients suffering from fragility fractures. Factors that influenced osteoporosis diagnosis and treatment rates were also assessed. To this end, patients ... -
Fibroblast Growth Factor 23 (FGF23) and Klotho Protein in Beta-Thalassemia
Stefanopoulos D., Nasiri-Ansari N., Dontas I., Vryonidou A., Galanos A., Psaridi L., Fatouros I.G., Mastorakos G., Papavassiliou A.G., Kassi E., Tournis S. (2020)Derangements in phosphate and calcium homeostasis are common in patients with beta-thalassemia. Fibroblast growth factor 23 (FGF23) is among the main hormones regulating phosphate levels, while several studies underline ... -
Introducing the “bleeding team”: Urgent reconstruction of an open fracture in a patient receiving acenocoumarol
Bareka M., Ntalouka M.P., Kolonia K., Koutalos A.A., Hantes M., Arnaoutoglou E. (2021)Case: An elderly, polytrauma patient receiving vitamin K antagonist (VKA) for atrial fibrillation required immediate surgery for open distal tibial fracture. As the initial reversal with vitamin K and fresh frozen plasma ...